White paperThe Enterprise Framework for Compliant, Scalable AI
Download now

Layer 0-5: A Life Sciences Operating Model for Claude Adoption

A six-layer operating model for adopting Claude in regulated life sciences — from intended use and governed context through connectors, skills, agents, and evidence-based governance. Start with structure, not demos.

Layer 0-5: A Life Sciences Operating Model for Claude Adoption

Claude adoption in life sciences should not begin with a tool rollout. It should begin with an operating model. Without one, organizations tend to accumulate disconnected pilots, inconsistent data practices, unapproved use cases, and unclear accountability. That is how AI enthusiasm becomes AI sprawl.

USDM uses a Layer 0-5 model to help regulated organizations sequence Claude adoption from strategy to execution. The model is intentionally practical: define the use case, govern the context, connect systems, package repeatable expertise, introduce agents carefully, and capture the evidence required to operate with confidence.

USDM Layer 0-5 operating model for Claude adoption in regulated life sciences
USDM’s Claude operating model puts intended use and governance underneath connectors, skills, and agentic workflows.

Layer 0: Intended use

Every serious Claude initiative needs a named intended use. “Let teams use AI” is not an intended use. A useful statement names the workflow, business owner, user population, source systems, expected outputs, review requirements, prohibited uses, and success criteria.

This layer is where organizations decide whether a use case is productivity support, business process support, GxP-adjacent, or part of a regulated workflow. An AI readiness assessment can help teams evaluate organizational maturity before committing to higher-risk deployments.

Layer 1: Governed context

Claude’s usefulness depends on context. Its risk also depends on context. Governed context means defining what content Claude can access, how permissions are inherited or enforced, what sensitive data is excluded, and which systems remain authoritative.

For life sciences, this layer often includes document classification, role design, data retention expectations, privacy boundaries, and source citation requirements. Organizations already managing data integrity programs will recognize the parallels.

Layer 2: Connectors and MCP

Connectors and MCP-based integrations are how Claude reaches the systems where work happens. Anthropic describes MCP as an open standard for connecting AI assistants to data sources. That makes it strategically important, but not automatically compliant.

USDM treats this layer as governed integration infrastructure. Access, scope, logging, testing, and change control must be explicit. For a deeper look at how these integration patterns work in practice, see MCP, connectors, and skills as a regulated AI integration layer.

Layer 3: Skills

Claude Skills can package instructions and repeatable expertise. In regulated organizations, that is useful because it can reduce prompt variation. It also means skills need owners, versions, testing, and release discipline when they support important workflows.

A skill used for an SOP impact summary or inspection readiness checklist should be managed differently from an informal productivity helper. The lifecycle discipline is similar to validation lifecycle management — define ownership, test boundaries, version changes, and monitor behavior.

Layer 4: Agent workflows

Agents introduce goal-directed execution across context and tools. That is where value can accelerate, but it is also where control failures become harder to detect after the fact. USDM recommends moving to agents only after the lower layers are clear enough to support bounded autonomy.

Agent workflow design should specify allowed actions, human approvals, exception handling, audit evidence, and monitoring metrics. USDM's approach to governing agents in GxP workflows provides a practical framework for this layer.

Layer 5: Governance and evidence

The final layer runs across all the others. Governance is not a committee at the end of the process. It is the evidence system that shows how Claude-enabled work is approved, tested, monitored, changed, and retired.

This layer includes AI policy, risk classification, validation strategy, vendor oversight, training, monitoring, incident handling, and management review.

Governance controls by layer

  • Layer 0 — Intended use: named owner, user population, prohibited uses, success criteria.
  • Layer 1 — Context: approved sources, data classification, exclusion rules, citation requirements.
  • Layer 2 — Connectors: access scope, logging, testing, change control, vendor oversight.
  • Layer 3 — Skills: ownership, versioning, release testing, monitoring, retirement.
  • Layer 4 — Agents: bounded autonomy, human approvals, exception routing, audit evidence.
  • Layer 5 — Governance: policy, risk classification, validation, incident handling, management review.

Why the sequence matters

Organizations often want to jump straight to agents because the demos are compelling. In life sciences, the smarter path is to build upward. Intended use and context come first. Connectors and skills come next. Agents come when the workflow has enough structure to be safe, valuable, and defensible.

That is the operating model behind USDM’s Anthropic Claude for life sciences approach and the reason we recommend starting with an AI Readiness Assessment before enterprise-wide rollout.

Frequently Asked Questions

What is the Layer 0-5 model?

It is a six-layer framework for sequencing Claude adoption in regulated life sciences: intended use, governed context, connectors and MCP, skills, agent workflows, and governance evidence. Each layer builds on the one below it.

Why not start with agents?

Agents require bounded autonomy, which depends on clear intended use, governed context, and controlled tools. Jumping to agents without the lower layers creates brittle automation with poor evidence and unclear accountability.

How does this relate to validation?

The model aligns validation expectations to risk. Low-risk productivity tools need lightweight controls. Skills and connectors supporting GxP workflows need documented testing and lifecycle management. Agent workflows in regulated processes need formal validation planning.

Where should an organization start?

Start with Layer 0: name the use case, the owner, the user population, the data sources, and the success criteria. Then assess organizational readiness before expanding into higher layers. Contact USDM to begin an AI readiness assessment.

Key takeaways

  • Claude adoption needs an operating model, not a loose collection of pilots.
  • USDM’s Layer 0-5 model sequences intended use, context, connectors, skills, agents, and governance evidence.
  • Connectors, MCP, and skills are control layers as much as technical features.
  • Agentic workflows should come after governance patterns are established, not before.

Ready to act on this?

Map the next practical step with USDM.

USDM can help translate the article topic into a defensible plan for your systems, teams, and regulatory context.

Explore capabilities

Find the USDM practice area most relevant to this topic.

Platform partners

See how USDM delivers outcomes on the platforms you use.

Related resources

Keep exploring

Hand-picked blogs, case studies, and guides on the same topic.

White Paper

2023 Technology Trends in Life Sciences

Explore five technology trends—automation, data collaboration platforms, cloud landing zones, AR/VR, and IoT—that help pharma, biotech, and medical device companies modernize while staying compliant. Download the white paper.

Read
Blog

Evaluating Google Agentspace for Life Sciences

A practical 10-factor framework for life sciences teams evaluating Google Agentspace—covering GxP compliance, data security, auditability, multi-agent governance, and ROI for confident, validated AI adoption.

Read
AI deploymentGovernance

Clinical-Stage Oncology Company Automates Regulated IT Workflows with ProcessX

Pre-commercial, clinical-stage precision oncology company with minimal existing IT systems and a need to scale regulated GxP operations rapidly.

Turning Point, a pre-commercial, clinical-stage precision oncology company, was achieving great clinical results needed to ramp up its IT systems rapidly.

Workflows requested

2

See proof
Blog

Validation Lifecycle Management: How Life Sciences Teams Stay Compliant Without Slowing Down

Validation lifecycle management helps life sciences organizations streamline compliance, reduce manual effort, and maintain audit-ready systems across implementation, change control, and ongoing operations.

Read
Blog

Implementing a Corporate Chargeback System for AI Citizen Development

Learn how a corporate chargeback system fairly allocates the costs and benefits of AI citizen development across business units, with a step-by-step model for transparent, accountable AI investment in life sciences.

Read
Webinar

An Update on the FDA’s UDI and GUDID Compliance Requirements

On-demand webinar with Jay Crowley on the FDA’s tightening UDI and GUDID requirements — closing Legacy Identifier gaps, UDI in routine inspections and import screening, and how labelers can align GUDID data across FDA systems before enforcement reaches them.

Read